The results showed that the upregulation of CTSZ was significantly correlated with poorer 5-year (P = 0.014, Fig. 1f) and 3-year (P = 0.022, Fig. 1g) survival of HCC patients. Here, CTSZ is linked to hepatocellular carcinoma.